anti-CD19 immunotoxin
{{Short description|Monoclonal antibody linked to a toxic substance}}
{{one source|date=April 2025}}
{{Use dmy dates|date=April 2025}}
Anti-CD19 immunotoxin is a monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD19 immunotoxin is made in the laboratory. It binds to CD19, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.
External links
- {{Cite web |url=http://www.cancer.gov/dictionary?CdrID=543121 |title= Anti-CD19 immunotoxin |access-date=22 February 2013 |archive-date=7 March 2013 |archive-url=https://web.archive.org/web/20130307085427/http://cancer.gov/dictionary?CdrID=543121 |url-status=live }} entry in the public domain NCI Dictionary of Cancer Terms
{{NCI-cancer-dict}}
Category:Monoclonal antibodies
{{antineoplastic-drug-stub}}